MedPath

The effect of the Jujube syrup on mild atopic dermatitis

Phase 3
Conditions
Atopic Dermatitis.
A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin, with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus.
Registration Number
IRCT20231118060097N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with atopic dermatitis based on physical examination and confirmation by a dermatologist
Absence of pregnancy and breastfeeding
Age 18 and above
Not having associated skin diseases
Not having diseases such as immune disorders and cancer
SCORAD less than 50

Exclusion Criteria

History of allergy to Jujube or Viola
Consumption of systemic corticosteroid by the patient
Failure to comply with the treatment protocol of drug use by the patient

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Redness and erythema. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.;Dryness. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.;Excoriation. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.;Itching. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.
Secondary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: 0, 3, 5 weeks. Method of measurement: DLQI questionnaire.
© Copyright 2025. All Rights Reserved by MedPath